Market Value362,250,156
Total Holdings76
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LRMR / Larimar Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MLYS / Mineralys Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
STOK / Stoke Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
IBB / iShares Trust - iShares Biotechnology ETF
FHTX / Foghorn Therapeutics Inc.
IPSC / Century Therapeutics, Inc.
IFRX / InflaRx N.V.
CMPX / Compass Therapeutics, Inc.
TELA / TELA Bio, Inc.
BCAX / Bicara Therapeutics Inc.
PHGE / BiomX Inc.
IDYA / IDEAYA Biosciences, Inc.
PRCT / PROCEPT BioRobotics Corporation
GOSS / Gossamer Bio, Inc.
ALKS / Alkermes plc
EWTX / Edgewise Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
ERAS / Erasca, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
STXS / Stereotaxis, Inc.
RCUS / Arcus Biosciences, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
RVMD / Revolution Medicines, Inc.
KRRO / Korro Bio, Inc.
LXEO / Lexeo Therapeutics, Inc.
NGNE / Neurogene Inc.
VYNE / VYNE Therapeutics Inc.
DNLI / Denali Therapeutics Inc.
BDTX / Black Diamond Therapeutics, Inc.
BHVN / Biohaven Ltd.
INGN / Inogen, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
ALLO / Allogene Therapeutics, Inc.
ITOS / iTeos Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
AXGN / Axogen, Inc.
ACET / Adicet Bio, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
KROS / Keros Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
DXCM / DexCom, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
PYPD / PolyPid Ltd.
URGN / UroGen Pharma Ltd.
KURA / Kura Oncology, Inc.
ADCT / ADC Therapeutics SA
ARAY / Accuray Incorporated
IMTX / Immatics N.V.
PODD / Insulet Corporation
TNDM / Tandem Diabetes Care, Inc.
PVLA / Palvella Therapeutics, Inc.
AQST / Aquestive Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
MRUS / Merus N.V.
MDWD / MediWound Ltd.
SPRY / ARS Pharmaceuticals, Inc.
TNYA / Tenaya Therapeutics, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
RGLS / Regulus Therapeutics Inc.
TSVT / 2seventy bio, Inc.
NVRO / Nevro Corp.
CRDF / Cardiff Oncology, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
XENE / Xenon Pharmaceuticals Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
APRE / Aprea Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
ATRC / AtriCure, Inc.
STRO / Sutro Biopharma, Inc.
ALEC / Alector, Inc.
ALGN / Align Technology, Inc.
NKTR / Nektar Therapeutics
CGEN / Compugen Ltd.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)